Decheng Capital LLC Top Holdings and 13F Report (2025) About Decheng Capital LLCInvestment ActivityDecheng Capital LLC has $466.23 million in total holdings as of December 31, 2024.Decheng Capital LLC owns shares of 28 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 25.74% of the portfolio was purchased this quarter.About 3.22% of the portfolio was sold this quarter.This quarter, Decheng Capital LLC has purchased 26 new stocks and bought additional shares in 10 stocks.Decheng Capital LLC sold shares of 5 stocks and completely divested from 2 stocks this quarter.Largest Holdings CG ONCOLOGY INC $182,739,467Nuvation Bio $69,038,808Upstream Bio Inc. $54,010,217NewAmsterdam Pharma $19,789,000Illumina $12,663,715 Largest New Holdings this Quarter Upstream Bio Inc. $54,010,217 HoldingLyell Immunopharma $7,621,978 HoldingAclaris Therapeutics $5,621,334 HoldingBioNTech $4,558,000 Holding Largest Purchases this Quarter Upstream Bio Inc. 3,285,293 shares (about $54.01M)CG ONCOLOGY INC 892,859 shares (about $25.61M)Revolution Medicines 224,000 shares (about $9.80M)Lyell Immunopharma 11,909,341 shares (about $7.62M)Aclaris Therapeutics 2,266,667 shares (about $5.62M) Largest Sales this Quarter Phathom Pharmaceuticals 555,746 shares (about $4.51M)Zentalis Pharmaceuticals 770,000 shares (about $2.33M)Arcus Biosciences 61,001 shares (about $908.30K)Vera Therapeutics 20,000 shares (about $845.80K)BeyondSpring 75,492 shares (about $123.05K) Sector Allocation Over TimeMap of 500 Largest Holdings ofDecheng Capital LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCG ONCOLOGY INC$182,739,467$25,607,196 ▲16.3%6,371,66939.2%COMNUVBNuvation Bio$69,038,8080.0%25,954,43914.8%MedicalUpstream Bio Inc.$54,010,217$54,010,217 ▲New Holding3,285,29311.6%COMNAMSNewAmsterdam Pharma$19,789,000$4,626,000 ▲30.5%770,0004.2%MedicalILMNIllumina$12,663,7150.0%94,7672.7%MedicalRCUSArcus Biosciences$12,042,868$908,305 ▼-7.0%808,7892.6%MedicalKRYSKrystal Biotech$12,027,102$783,300 ▲7.0%76,7722.6%MedicalRVMDRevolution Medicines$9,885,240$9,797,760 ▲11,200.0%226,0002.1%MedicalMOONLAKE IMMUNOTHERAPEUTICS$9,292,140$270,750 ▲3.0%171,6002.0%COMCRNXCrinetics Pharmaceuticals$8,587,693$511,300 ▲6.3%167,9581.8%MedicalBYSIBeyondSpring$7,958,721$123,052 ▼-1.5%4,882,6511.7%MedicalMRUSMerus$7,951,5710.0%189,0981.7%MedicalLYELLyell Immunopharma$7,621,978$7,621,978 ▲New Holding11,909,3411.6%MedicalZNTLZentalis Pharmaceuticals$7,084,428$2,333,100 ▼-24.8%2,338,0951.5%MedicalACLXArcellx$6,470,872$4,846,808 ▲298.4%84,3771.4%MedicalPHATPhathom Pharmaceuticals$5,637,342$4,512,657 ▼-44.5%694,2541.2%MedicalACRSAclaris Therapeutics$5,621,334$5,621,334 ▲New Holding2,266,6671.2%MedicalLEGNLegend Biotech$4,996,777$1,464,300 ▲41.5%153,5581.1%MedicalCYTKCytokinetics$4,704,000$280,217 ▲6.3%100,0001.0%MedicalBNTXBioNTech$4,558,000$4,558,000 ▲New Holding40,0001.0%MedicalAURAAura Biosciences$4,237,8620.0%515,5550.9%MedicalEQEquillium$3,327,4760.0%4,447,3080.7%MedicalFDMT4D Molecular Therapeutics$2,228,000$12,059 ▲0.5%400,0000.5%MedicalVERAVera Therapeutics$2,104,646$845,800 ▼-28.7%49,7670.5%MedicalATRCAtriCure$818,9160.0%26,7970.2%MedicalPYXSPyxis Oncology$509,8240.0%326,8100.1%MedicalGRAIL INC$172,8590.0%9,6840.0%COMNuvation Bio Inc.$148,5930.0%646,0570.0%WARRANTSWGSGeneDx$0$4,396,950 ▼-100.0%00.0%MedicalLBPHLongboard Pharmaceuticals$0$1,878,146 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
